Cargando…
Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG
BACKGROUND: Chagas disease, caused by Trypanosoma cruzi, affects nearly six million people worldwide. Various serological tests have been developed for its diagnosis. OBJECTIVE: Examine the performance of a set of commercial immunological assays in relation to the geographical origin of the patient...
Autores principales: | Sáez-Alquezar, Amadeo, Junqueira, Angela Cristina Verissimo, Durans, Andressa da Matta, Guimarães, André Valpassos, Corrêa, José Abol, Borges-Pereira, José, Zauza, Patrícia Lago, Cabello, Pedro Hernan, Albajar-Viñas, Pedro, Provance, David William, Coura, José Rodrigues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168343/ http://dx.doi.org/10.1590/0074-02760210032 |
Ejemplares similares
-
Application of WHO International Biological Reference Standards to evaluate commercial serological tests for chronic Chagas disease
por: Sáez-Alquezar, Amadeo, et al.
Publicado: (2020) -
Quality Control in Screening for Infectious Diseases at Blood Banks. Rationale and Methodology
por: Sáez-Alquezar, Amadeo, et al.
Publicado: (2015) -
Ecoepidemiology, short history and control of Chagas disease in the
endemic countries and the new challenge for non-endemic countries
por: Coura, José Rodrigues, et al.
Publicado: (2014) -
Chagas disease in Virgem da Lapa, Minas Gerais, Brazil: left ventricle aneurysm and the risk of death in the 24-year interval
por: Borges-Pereira, José, et al.
Publicado: (2020) -
Nicastrin-Like, a Novel Transmembrane Protein from Trypanosoma cruzi Associated to the Flagellar Pocket
por: Lechuga, Guilherme Curty, et al.
Publicado: (2021)